Cargando…
Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
Given the limited accuracy of clinically used risk scores such as the Systematic COronary Risk Evaluation 2 system and the Second Manifestations of ARTerial disease 2 risk scores, novel risk algorithms determining an individual’s susceptibility of future incident or recurrent atherosclerotic cardiov...
Autores principales: | Nurmohamed, Nick S, Kraaijenhof, Jordan M, Mayr, Manuel, Nicholls, Stephen J, Koenig, Wolfgang, Catapano, Alberico L, Stroes, Erik S G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163980/ https://www.ncbi.nlm.nih.gov/pubmed/36988179 http://dx.doi.org/10.1093/eurheartj/ehad161 |
Ejemplares similares
-
Different inflammatory pathways underlying cardiovascular risk in secondary prevention( )
por: Nurmohamed, Nick S, et al.
Publicado: (2022) -
Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy
por: Kraaijenhof, Jordan M., et al.
Publicado: (2023) -
Targeted proteomics improves cardiovascular risk prediction in secondary prevention
por: Nurmohamed, Nick S., et al.
Publicado: (2022) -
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
por: Tada, Hayato, et al.
Publicado: (2021) -
Lp(a): a New Pathway to Target?
por: Nurmohamed, Nick S., et al.
Publicado: (2022)